Jug Group awarded CZI grants to support advancement of imaging technologies
Members of the Jug Group, Florian Jug, Joran Deschamps and Christopher Schmied, have been awarded two $20.000 grants for the creation of napari plugins. The grants are awarded by the Chan Zuckerberg Initiative (CZI) as part of a wider effort to advance technologies and expand global access to bioimaging.
napari is a community-built software used to view and analyse large multi-dimensional images. The tool enables Python practitioners, biologists, and other scientists to leverage Python’s scientific resources without the need for prior coding experience. The plugins proposed by the Jug Group will give users wide access to user-friendly cutting-edge methods for denoising and segmentation of images.
The two proposals are in line with the wider aim of the Jug Group to push the boundaries of what image analysis and Machine Learning can do for quantifying biological (image) data, by developing advanced, cutting-edge methods and sharing them with the wider research community.
To this end, and in line with Human Technopole’s mission to train the next generation of leading scientists, the Jug Group also regularly organises workshops to familiarise researchers working in life sciences with state-of-the-art deep learning techniques for microscopy image analysis, with a focus on image denoising and segmentation.
The next course “Deep learning for microscopy image analysis”, open to 24 students, will take place virtually from 22 to 26 November with the participation of lecturers from EMBL, University of Birmingham, CZ Biohub, EMBL-EBI and EPFL.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.